WO2007036352A3 - Candida-diagnose-chip - Google Patents

Candida-diagnose-chip Download PDF

Info

Publication number
WO2007036352A3
WO2007036352A3 PCT/EP2006/009363 EP2006009363W WO2007036352A3 WO 2007036352 A3 WO2007036352 A3 WO 2007036352A3 EP 2006009363 W EP2006009363 W EP 2006009363W WO 2007036352 A3 WO2007036352 A3 WO 2007036352A3
Authority
WO
WIPO (PCT)
Prior art keywords
candida
diagnosing
chip
biochips
protein
Prior art date
Application number
PCT/EP2006/009363
Other languages
English (en)
French (fr)
Other versions
WO2007036352A2 (de
Inventor
Nicole Hauser
Steffen Rupp
Achim Weber
Guenter Tovar
Ekkehard Hiller
Kirsten Borchers
Original Assignee
Fraunhofer Ges Forschung
Univ Stuttgart
Nicole Hauser
Steffen Rupp
Achim Weber
Guenter Tovar
Ekkehard Hiller
Kirsten Borchers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung, Univ Stuttgart, Nicole Hauser, Steffen Rupp, Achim Weber, Guenter Tovar, Ekkehard Hiller, Kirsten Borchers filed Critical Fraunhofer Ges Forschung
Priority to CA002623727A priority Critical patent/CA2623727A1/en
Priority to US12/066,136 priority patent/US20080293079A1/en
Priority to JP2008532658A priority patent/JP2009510416A/ja
Priority to EP06792283A priority patent/EP1931991A2/de
Publication of WO2007036352A2 publication Critical patent/WO2007036352A2/de
Publication of WO2007036352A3 publication Critical patent/WO2007036352A3/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nanotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die vorliegende Erfindung betrifft Mittel und Verfahren zum Nachweis von Candida und Candida-verwandten Pilzzellen in klinischem Material mittels Protein-Biochips.
PCT/EP2006/009363 2005-09-28 2006-09-27 Candida-diagnose-chip WO2007036352A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002623727A CA2623727A1 (en) 2005-09-28 2006-09-27 Chip for diagnosing the presence of candida
US12/066,136 US20080293079A1 (en) 2005-09-28 2006-09-27 Chip for Diagnosing the Presence of Candida
JP2008532658A JP2009510416A (ja) 2005-09-28 2006-09-27 カンジダ診断チップ
EP06792283A EP1931991A2 (de) 2005-09-28 2006-09-27 Candida-diagnose-chip

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005047384A DE102005047384A1 (de) 2005-09-28 2005-09-28 Candida-Diagnostik-Chip
DE102005047384.9 2005-09-28

Publications (2)

Publication Number Publication Date
WO2007036352A2 WO2007036352A2 (de) 2007-04-05
WO2007036352A3 true WO2007036352A3 (de) 2007-06-07

Family

ID=37852775

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/009363 WO2007036352A2 (de) 2005-09-28 2006-09-27 Candida-diagnose-chip

Country Status (7)

Country Link
US (1) US20080293079A1 (de)
EP (1) EP1931991A2 (de)
JP (1) JP2009510416A (de)
KR (1) KR20080049827A (de)
CA (1) CA2623727A1 (de)
DE (1) DE102005047384A1 (de)
WO (1) WO2007036352A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5239978B2 (ja) * 2009-03-23 2013-07-17 パナソニック株式会社 センサおよびシーケンサー
US20150245532A1 (en) * 2014-02-24 2015-08-27 Acta Technology Inc. Self modulating air register technology (smart) floor tile for data centers and other applications

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088741A1 (en) * 2001-04-25 2002-11-07 Rockeby Biomed Ltd Detection of candida
WO2003056336A2 (de) * 2001-12-28 2003-07-10 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verbesserte strukturiert-funktionale bindematrices für biomoleküle
WO2004101612A2 (de) * 2003-05-16 2004-11-25 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Thioredoxin-peroxidase von c. albicans als virulenzspezifischer marker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088741A1 (en) * 2001-04-25 2002-11-07 Rockeby Biomed Ltd Detection of candida
WO2003056336A2 (de) * 2001-12-28 2003-07-10 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verbesserte strukturiert-funktionale bindematrices für biomoleküle
WO2004101612A2 (de) * 2003-05-16 2004-11-25 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Thioredoxin-peroxidase von c. albicans als virulenzspezifischer marker

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BORCHERS K ET AL: "Microstructured layers of spherical biofunctional core-shell nanoparticles provide enlarged reactive surfaces for protein microarrays", ANALYTICAL AND BIOANALYTICAL CHEMISTRY, XX, DE, vol. 383, no. 5, November 2005 (2005-11-01), pages 738 - 746, XP002373936, ISSN: 1618-2642 *
KONDORI N ET AL: "CANDIDA ALBICANS CELL WALL ANTIGENS FOR SEROLOGICAL DIAGNOSIS OF CANDIDEMIA", MEDICAL MYCOLOGY, OXFORD, GB, vol. 41, no. 1, February 2003 (2003-02-01), pages 21 - 30, XP008025341, ISSN: 1369-3786 *
URBAN C ET AL: "Identification of cell surface determinants in Candida albicans reveals Tsa1p, a protein differentially localized in the cell", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 544, no. 1-3, 5 June 2003 (2003-06-05), pages 228 - 235, XP004427898, ISSN: 0014-5793 *

Also Published As

Publication number Publication date
DE102005047384A1 (de) 2007-04-05
JP2009510416A (ja) 2009-03-12
US20080293079A1 (en) 2008-11-27
KR20080049827A (ko) 2008-06-04
WO2007036352A2 (de) 2007-04-05
CA2623727A1 (en) 2007-04-05
EP1931991A2 (de) 2008-06-18

Similar Documents

Publication Publication Date Title
WO2008033427A3 (en) Compositions and methods for detection of lysosomal storage disease
WO2008014280A3 (en) Flourescent dyes for use in glucose sensing
WO2006089091A3 (en) Methods for detecting minimum residual disease
WO2007062090A3 (en) Methods and compositions related to b cell assays
WO2011047087A3 (en) Protein detection via nanoreporters
WO2008108803A3 (en) Immune cell biosensors and methods of using same
WO2006091734A3 (en) Compositions and methods for classifying biological samples
WO2006017134A3 (en) Preprimitive streak and mesendoderm cells
WO2006085984A3 (en) Immune cell biosensors and methods of using same
WO2006076025A3 (en) Immune cell biosensors and methods of using same
WO2006073439A3 (en) Surface enhanced spectroscpy-active composite nanop articles and their application in analysis and diagnosis
WO2006010150A3 (en) Housekeeping genes and methods for identifying the same
WO2007140352A3 (en) Plasma membrane and secreted cancer biomarkers
WO2007149105A3 (en) Fluorescein based sensors for tracking nitric oxide in live cells
EP1774330A4 (de) Verfahren zum nachweis von molekularen wechselwirkungen in zellen
EP1946108A4 (de) Acridiniumverbindungen mit hoher quantenausbeute und deren verwendungen bei der verbesserung der testempfindlichkeit
WO2009007846A3 (en) Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins
WO2011087709A3 (en) Eml4-alk translocations in lung cancer
WO2011143574A3 (en) Plasma biomarkers for diagnosis of alzheimer's disease
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
WO2009082445A3 (en) Novel devices for the detection of the presence and/or activity of proteases in biological samples
WO2006135799A3 (en) Detection of hookworm coproantigens
EP2269065A4 (de) Verfahren und reagenzien zur erhöhung der empfindlichkeit metallographischer enzymerkennungen
GB0505777D0 (en) Enzyme detection method and reagent
WO2005067580A3 (en) Naphthofluorescein-based metal sensors, and methods of making and using the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2006792283

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2623727

Country of ref document: CA

Ref document number: 2008532658

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020087009182

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 12066136

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2006792283

Country of ref document: EP